Key takeaways:
- IBS is one of the leading causes of work absenteeism, second only to the common cold, with an annual toll estimated at $21 billion USD.
- Research presented by Dr. Simone Peters showed a digital therapeutic like Nerva has the potential to cut long-term IBS management costs by around 50% while improving work performance.
- In her study of 4,200 patients, spending on IBS symptom management dropped from $1,259 USD to $644 USD after six weeks of Nerva, later stabilizing at $502 USD.
- The research demonstrated app-delivered gut-directed hypnotherapy is more cost-effective and accessible than face-to-face therapy, with sustained improvements in absenteeism and daily functioning.
This blog explores the significant financial burden of IBS and shares new research showing how digital gut-directed hypnotherapy can cut management costs in half while improving patients’ daily functioning.
A multi-billion dollar burden
“It turns out that IBS is one of the leading causes of work absenteeism, second only to the common cold,” said gastroenterologist Dr. Bill Chey from the University of Michigan.
Researchers reported that the annual toll of IBS, which combines direct medical expenses with productivity losses due to work absenteeism, amounts to a staggering $21 billion USD.
Annual costs are substantially higher for those with severe gastrointestinal symptoms and comorbid depression, and as the number of psychological comorbidities increases, the severity of IBS symptoms intensifies.
.webp)

